Search:
« Risk Of Relapse For Patients With Anorexia Nervosa Not Decreased By Use Of Anti-depressant
Obesity tied to hepatitis C treatment failure (Reuters) »

Galvus Combination Lowers HbA1c By Up To 2.8%

Galvus combined with pioglitazone reduces HbA1c by up to 2.8% in type two diabetes patients, say Galvus makers, Novartis. Compared with pioglitazone alone, with the Galvus combination there is no significant weight gain and less edema. Galvus, a member of the DPP-4 inhibitor class, is awaiting FDA approval as a once daily oral treatment for type two diabetes patients. [click link for full article]

More: continued here

This entry was posted on Sunday, June 18th, 2006 at 8:06 am and is filed under Obesity. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply
Sign Up for a free account or learn more.
Submit Articles
Member Login
Top Authors
Most Popular Articles
Submission Guidelines
Ezine Notifications
Article RSS Feeds
About Us
Link to Us
Contact Us
Privacy Policy
Terms of Service
Sponsored Links
center>
Resources
Diet Sites
Food Information
Diet Pills
Fitness Resources
Health Help
Women's Links
Men's Links

Powered by Article Dashboard

Related News


  • Breast Cancer Risk Increased With Weight Gain In Postmenopausal Women
    Weight gain, particularly after menopause, is associated with an increased risk of breast cancer in women, according to an article in the July 12 issue of JAMA.Background information in the article indicates that weight loss after menopause lowers circulating estrogen hormones in women, and because estrogen is directly related to breast cancer, weight loss is thought to decrease risk of the disease. [click link for full article]


  • Number of Obese, Smoking Americans Tops 9 Million (HealthDay)
    HealthDay - FRIDAY, May 12 (HealthDay News) -- Some nine million Americans suffer from the potentially deadly combination of smoking and obesity, a new analysis of federal data finds.


  • The Diabetes Epidemic - Obesity A Major Factor
    More and more Americans are being diagnosed with diabetes. Is this rise in cases due to better testing, a change in diagnostic criteria, a true rise in incidence, or some combination of these and other factors? In a study in the May issue of the American Journal of Preventive Medicine, researchers from the Centers for Disease Control and Prevention examine some of the reasons for this increase. [click link for full article]


  • New Insights Into How Major Weight-loss Drugs Work
    Some of the most important weight-loss drugs work by enhancing the effect of the brain chemical serotonin. These include sibutramine (trade name Meridia) and fenfluramine, which was recalled after the combination with dexfenfluramine, called fen-phen, was linked to potentially fatal heart valve abnormalities.However, little has been known about the molecular mechanism by which serotonin suppresses appetite. [click link for full article]


  • Treating Obesity May Improve The Efficacy Of Therapy For Hepatitis C
    According to a new study, obese patients chronically infected with the hepatitis C virus (HCV) and treated with combination drug therapy may have better outcomes if the underlying abnormalities caused by excessive fat tissue are corrected. Weight loss, medications to decrease insulin resistance and extending duration or dosage of therapy are strategies that may improve the efficacy of therapy. [click link for full article]